TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven (TRUE HAVEN)

February 11, 2026 updated by: Yale University

TRUE HAVEN: TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

The overall objective of this study is to implement and test a strengths-based, community-driven intervention to reduce gun violence by (1) improving housing stability through providing financial assistance coupled with comprehensive financial education for the re-entry population as well as their family members, and (2) fostering greater support for mental health by training a trusted network of community members in trauma-informed counseling.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Proposed is a type I hybrid effectiveness/implementation study using a neighborhood-level, stepped-wedge trial design across seven primarily socially vulnerable neighborhoods in New Haven. Residents of each neighborhood who have been affected by incarceration (i.e., currently have a family member incarcerated or a person returning to the community from prison within the last 12 months) will be eligible for our intervention for a period of 6 months. The Consolidated Framework for Implementation Research (CFIR) and the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) implementation science frameworks will be used to measure and track processes in achieving outcomes. A mixed methods approach will be used, primarily the use of quantitative methods for this study, along with qualitative focus groups will be conducted to assess some implementation outcomes. The primary outcome, rates of gun violence at the neighborhood level, are obtained from administrative data. Survey data will be collected for some implementation process measures (e.g., assessing acceptability and appropriateness of the intervention).

Study Type

Interventional

Enrollment (Estimated)

61770

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Connecticut
      • New Haven, Connecticut, United States, 06511
      • New Haven, Connecticut, United States, 06514
        • Recruiting
        • Newhallville
        • Contact:
        • Sub-Investigator:
          • Christine Montgomery
        • Principal Investigator:
          • Virginia Spell
      • New Haven, Connecticut, United States, 06513
        • Recruiting
        • Fair Haven
        • Contact:
        • Sub-Investigator:
          • Christine Montgomery
        • Principal Investigator:
          • Virginia Spell
      • New Haven, Connecticut, United States, 06513
        • Recruiting
        • Hill North and South
        • Contact:
        • Sub-Investigator:
          • Christine Montgomery
        • Principal Investigator:
          • Virginia Spell
      • New Haven, Connecticut, United States, 06511
        • Recruiting
        • Dixwell
        • Sub-Investigator:
          • Christine Montgomery
        • Principal Investigator:
          • Virginia Spell
        • Contact:
      • New Haven, Connecticut, United States, 06511
        • Recruiting
        • Dwight/West River
        • Sub-Investigator:
          • Christine Montgomery
        • Principal Investigator:
          • Virginia Spell
        • Contact:
      • New Haven, Connecticut, United States, 06515
        • Recruiting
        • West Rock/West Hills
        • Sub-Investigator:
          • Christine Montgomery
        • Principal Investigator:
          • Virginia Spell
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

All residents in the study neighborhoods are eligible for outcome assessment. For the intervention component of housing support, the below inclusion and exclusion criteria apply.

Inclusion criteria:

  • Age 18 or above
  • Family member currently incarcerated or person returning from prison within the last 12 months
  • Live in one of the seven neighborhoods with highest rates of gun violence in New Haven, Connecticut

Exclusion criteria:

  • Plans to leave the study area within 1 year

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: Intervention
The two components in the intervention arm of TRUE HAVEN are: housing support for recently incarcerated people as well as family members of currently incarcerated people, and mental wellness training for neighborhood residents to participate in trauma-informed care training sessions.
Behavioral: TRUE HAVEN
The two components of the TRUE HAVEN intervention are: housing support for recently incarcerated people as well as family members of currently incarcerated people, and mental wellness training for neighborhood residents to participate in trauma-informed care training sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in rates of gun violence
Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months
The neighborhood rate of incident gun violence assessed among everyone in the neighborhoods; these data will be provided annually by the New Haven Police Department.
Baseline, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in neighborhood social cohesion using the Social Cohesion sub-scale of the Sampson Collective Efficacy Scale
Time Frame: Baseline, 6 months, 12 months, and 24 months
This is a neighborhood-level outcome on residents' perception of the strengths of relationships and solidarity among their neighbors. Data will be provided annually from DataHaven based on a representative sample of approximately 1% of population across each neighborhood of New Haven. The measure is based on Social Cohesion sub-scale of the Sampson Collective Efficacy Scale, which is a 5-point scale (score range: 1(strongly disagree) to 5(strongly agree)).
Baseline, 6 months, 12 months, and 24 months
Change in financial security
Time Frame: Baseline, 6 months, 12 months, and 24 months
Financial readiness for an emergency will be assessed using a survey among the recruited participants. The measure is based on one 5-point item (score range: 1(worst) to 5(best)) measuring financial capability.
Baseline, 6 months, 12 months, and 24 months
Change in participant self-efficacy based on the Generalized Self-Efficacy Scale
Time Frame: Baseline, 6 months, 12 months, and 24 months
Individual-level perceptions and reactions to life's situations will be measured using a survey among the about 700 recruited participants. The measure is based on the Generalized Self-Efficacy Scale, which is a 4-point scale (score range: 1(not at all true) to 4(exactly true)).
Baseline, 6 months, 12 months, and 24 months
Change in perceived health and well-being based on the Well-being Assessment
Time Frame: Baseline, 6 months, 12 months, and 24 months
Individual-level perceived health and well-being including dimensions of subjective well-being, general health, health problems, sense of direction and purpose in life, emotional support, and sense of belonging to community will be measured using a survey among the about 700 recruited participants. This composite measure is based on Well-being Assessment (Adult - 12 items) - 100 Million Healthier Lives. Each item is an 11-point scale (score range: 0(worst) to 10(best)). Higher scores indicate better perceived health and well-being.
Baseline, 6 months, 12 months, and 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yale University

Collaborators

National Institute on Minority Health and Health Disparities (NIMHD)

Investigators

  • Principal Investigator: Emily Wang, MD, MAS, Yale University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

February 1, 2023

First Submitted That Met QC Criteria

February 1, 2023

First Posted (Actual)

February 13, 2023

Study Record Updates

Last Update Posted (Actual)

February 13, 2026

Last Update Submitted That Met QC Criteria

February 11, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2000032184
  • 1R01MD017526-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified data will be made publicly available following study completion.

IPD Sharing Time Frame

One year following the end of the funding.

IPD Sharing Access Criteria

One year after the end of study funding, the de-identified data will be available upon request to the principal investigators of the study (Brita Roy, Brita.Roy@nyulangone.org; Virginia Spell, vtspell@ulsc.org; Emily Wang, emily.wang@yale.edu)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Firearm Injury

Clinical Trials on TRUE HAVEN

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe